News.bms.com

Bristol Myers Squibb

WebCamzyos is the first and only FDA-approved cardiac myosin inhibitor that specifically targets the source of obstructive HCM Approval based on groundbreaking …

Actived: 5 days ago

URL: https://news.bms.com/news/details/2022/U.S.-Food-and-Drug-Administration-Approves-Camzyos-mavacamten-for-the-Treatment-of-Adults-With-Symptomatic-New-York-Heart-Association-Class-II-III-ObstructiveHypertrophic-Cardiomyopathy-HCM-to-Improve-Functional-Capacity-and-Symptoms/default.aspx

Bristol Myers Squibb

WebFollowing four years of continuous Sotyktu treatment, clinical response was maintained in more than seven out of 10 patients for Psoriasis Area and Severity Index …

Category:  Health Go Health

Bristol Myers Squibb

WebApplication based on results from CheckMate -67T, the first Phase 3 trial of the subcutaneous formulation of nivolumab to evaluate and demonstrate noninferior …

Category:  Health Go Health

Bristol Myers Squibb

WebCompany Awards $1.8M in Grants to Eight Organizations in Brazil, India, Thailand and the United Kingdom Bristol Myers Squibb (NYSE: BMY) today unveiled a …

Category:  Health Go Health

Bristol Myers Squibb Donates $11 Million to Advance Health Equity

WebDelivering on commitments announced in 2020, BMS donates funds to 56 nonprofits serving medically underserved populations across the U.S. Bristol Myers …

Category:  Medical Go Health

Bristol Myers Squibb

WebNew clinical analyses and real-world data continue to demonstrate the benefit of treatment with CAMZYOS ® ( mavacamten ) for patients with symptomatic obstructive …

Category:  Health Go Health

Bristol Myers Squibb

WebBristol Myers Squibb (NYSE:BMY) today announced, in collaboration with Disability Solutions, a U.S.- based non-profit organization that supports companies …

Category:  Health Go Health

Bristol Myers Squibb

WebBristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the TD Cowen 44 th Annual Health Care Conference in Boston, …

Category:  Health Go Health

Voluntis and Bristol-Myers Squibb to Co-Develop Digital …

WebVoluntis (Euronext Paris, Ticker: VTX - ISIN: FR0004183960), a leader in digital therapeutics, and Bristol-Myers Squibb Company (NYSE:BMY) today announced …

Category:  Health Go Health

Bristol Myers Squibb Foundation Honors Diversity and Health …

WebThe groundbreaking, uniquely robust Robert A. Winn Diversity in Clinical Trials Award Program is on track to train more than 500 individuals from diverse …

Category:  Health Go Health

Bristol Myers Squibb

WebNew Educational Program Improves Science Education, Focuses on Career Opportunities More than 75 Newark high school students and teachers today probe the …

Category:  Health Go Health

Bristol Myers Squibb

WebCompany builds on its strengths to advance patient access, product innovation, culture and inclusion and diversity Bristol Myers Squibb (NYSE: BMY) today …

Category:  Health Go Health

Bristol Myers Squibb Board Elects Two New Independent Directors

WebBristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected two new independent directors, Ms. Paula A. Price and Mr. Derica …

Category:  Health Go Health

Bristol Myers Squibb

WebIn light of the COVID-19 pandemic, GRYT Health (“grit”), a digital health company with a social purpose and creator of the Global Virtual Cancer Conference and …

Category:  Cancer Go Health

Bristol Myers Squibb

WebBristol-Myers Squibb Company (NYSE: BMY) today announced Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved Opdivo (nivolumab) for the …

Category:  Health Go Health

Bristol Myers Squibb

WebBristol-Myers Squibb Company (NYSE:BMY) today announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Opdivo …

Category:  Health Go Health

Bristol-Myers Squibb Announces Offer from Taisho Pharmaceutical

WebStrategic review process announced in June concludes with a project to sell UPSA consumer health business The potential transaction would position Bristol-Myers …

Category:  Health Go Health

Bristol Myers Squibb Reports Second Quarter 2020 Financial Results

WebBristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and …

Category:  Health Go Health

Bristol Myers Squibb

WebBristol Myers Squibb (NYSE: BMY) today announced an expansion of its existing patient support programs to help eligible unemployed patients in the U.S. who …

Category:  Health Go Health

Bristol Myers Squibb

WebGlobal advocacy platform born out of need during COVID-19 expands offerings with the goal of helping better support patients as they navigate health care …

Category:  Health Go Health

Bristol-Myers Squibb Announces Leadership Changes

WebNEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that John Elicker, Executive Vice President, Corporate …

Category:  Health Go Health

Updated Statement: Bristol Myers Squibb on Coronavirus (COVID …

WebThroughout the unprecedented and evolving COVID-19 pandemic, Bristol Myers Squibb has focused on protecting the health and safety of our workforce, …

Category:  Health Go Health